71 patents
Utility
Methods of Treating Tuberous Sclerosis Complex with Cannabidiol and Everolimus
10 Feb 22
The present disclosure provides methods of treating tuberous sclerosis complex comprising administering cannabidiol and everolimus.
Geoffrey GUY, Volker KNAPPERTZ, Eduardo DUNAYEVICH, David CRITCHLEY
Filed: 25 Oct 21
Utility
Use of Cannabinoids In the Treatment of Epilepsy
27 Jan 22
The present invention relates to the use of cannabidiol (CBD) in the treatment of epilepsy which results from mutation of the KCNT1 gene.
Geoffrey GUY, Volker KNAPPERTZ
Filed: 18 Feb 20
Utility
Parenteral formulations
25 Jan 22
The present invention relates to parenteral cannabinoid formulations, and more particularly to cannabinoid containing intravenous (IV) formulations.
Stephen Wright, Jitinder Wilkhu
Filed: 29 Jun 17
Utility
Cannabidiol-type Cannabinoid Compound
20 Jan 22
The present invention relates to a cannabidiol (CBD) type cannabinoid compound for use as a medicament.
Geoffrey GUY, Volker KNAPPERTZ, Benjamin WHALLEY, Royston GRAY, Jacqueline CILIA, Amesha PATEL, Hannah STRAKER
Filed: 20 Nov 19
Utility
Use of Cannabinolids In the Treatment of Epilepsy
13 Jan 22
The present invention relates to the use of cannabidiol (CBD) in the treatment of epilepsy which results from mutation of the GRIN2A gene.
Geoffrey GUY, Volker KNAPPERTZ
Filed: 28 Nov 19
Utility
Use of Cannabinoids In the Treatment of Epilepsy
6 Jan 22
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures.
Geoffrey Guy, Stephen Wright, Orrin Devinsky
Filed: 16 Sep 21
Utility
Use of Cannabinoids In the Treatment of Epilepsy
30 Dec 21
The present disclosure relates to the use of cannabidiol (CBD) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE).
Geoffrey GUY, Stephen WRIGHT, Orrin DEVINSKY
Filed: 10 Sep 21
Utility
Cannabidiol preparations and its uses
28 Dec 21
Cannabidiol (CBD) is a cannabinoid designated chemically as 2-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol.
Geoffrey Guy, Volker Knappertz, Benjamin Whalley, Marie Woolley-Roberts, James Brodie, Katarzyna Lach-Falcone, Alan Sutton, Royston Gray, Rohini Rajyalaxmi Rana
Filed: 3 Sep 20
Utility
pH dependent release coated microparticle cannabinoid formulations
2 Nov 21
The present disclosure provides a microparticulate comprising one or more cannabinoids and a pH dependent release polymer.
Jitinder Wilkhu, Alan Silcock
Filed: 12 Oct 20
Utility
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
2 Nov 21
The present disclosure provides methods of treating tuberous sclerosis complex comprising administering cannabidiol and everolimus.
Geoffrey Guy, Volker Knappertz, Eduardo Dunayevich, David Critchley
Filed: 1 Mar 21
Utility
Use of Cannabidiol In the Treatment of Epilepsy
28 Oct 21
The present disclosure relates to the use of cannabidiol (CBD) for the reduction of seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE).
Geoffrey GUY, Stephen WRIGHT, Orrin DEVINSKY
Filed: 21 Jul 20
Utility
Use of cannabinoids in the treatment of epilepsy
26 Oct 21
The present disclosure relates to the use of cannabidiol (CBD) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE).
Geoffrey Guy, Stephen Wright, Orrin Devinsky
Filed: 11 Dec 20
Utility
Use of cannabinoids in the treatment of epilepsy
26 Oct 21
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures.
Geoffrey Guy, Stephen Wright, Orrin Devinsky
Filed: 27 Apr 21
Utility
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy
19 Oct 21
The present invention relates to the use of 7-hydroxy-cannabidol (7-OH-CBD) and/or 7-hydroxy-cannabidivarin (7-OH-CBDV) in the treatment of epilepsy.
Colin Stott, Nick Jones, Benjamin Whalley, Gary Stephens, Claire Williams
Filed: 3 Oct 19
Utility
Use of cannabinoids in the treatment of epilepsy
19 Oct 21
The present invention relates to the use of a therapeutically effective amount of cannabidiolic acid (CBDA) in the treatment of epilepsy.
Colin Stott, Nicholas Jones, Robin Williams, Benjamin Whalley
Filed: 29 Jul 16
Utility
Combination of Cannabinoids In the Treatment of Leukaemia
7 Oct 21
The present invention relates to the use of a combination of two different cannabinoids in the treatment of leukaemia.
Stephen Wright, Wai Liu, Katherine Scott, Angus Dalgleish
Filed: 15 Apr 21
Utility
Use of Cannabidiol In the Treatment of Epilepsy
23 Sep 21
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC).
Geoffrey GUY, Stephen Wright, Elizabeth Thiele
Filed: 7 Jun 21
Utility
Methods of Treating Tuberous Sclerosis Complex with Cannabidiol and Everolimus
2 Sep 21
The present disclosure provides methods of treating tuberous sclerosis complex comprising administering cannabidiol and everolimus.
Geoffrey GUY, Volker KNAPPERTZ, Eduardo DUNAYEVICH, David CRITCHLEY
Filed: 1 Mar 21
Utility
Use of cannabinoids in the treatment of epilepsy
24 Aug 21
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures.
Geoffrey Guy, Stephen Wright, Orrin Devinsky
Filed: 11 Mar 21
Utility
Use of Cannabinoids In the Treatment of Epilepsy
12 Aug 21
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures.
Geoffrey Guy, Stephen Wright, Orrin Devinsky
Filed: 27 Apr 21